Daniel Corey
Chief Executive Officer at CERo Therapeutics, Inc.
Net worth: 946 773 $ as of 2024-04-29
Profile
Daniel Mark Corey is the founder of CERo Therapeutics, Inc. which was founded in 2018.
He holds the title of Chief Executive & Technology Officer at CERo Therapeutics, Inc. Currently, Dr. Corey is the Director & Chief Technical Officer at CERo Therapeutics Holdings, Inc. since 2021.
Dr. Corey's education includes an undergraduate degree from Brown University and a doctorate degree from UW Medicine.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
4.56% | 2024-04-04 | 671,470 ( 4.56% ) | 946 773 $ | 2024-04-29 |
Daniel Corey active positions
Companies | Position | Start |
---|---|---|
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Chief Executive Officer | 2017-12-31 |
Training of Daniel Corey
Brown University | Undergraduate Degree |
UW Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Daniel Corey